A new and highly potent synthetic opioid, Isotonitazene (ISO), has emerged in the U.S. illicit drug market, raising alarms among health officials and law enforcement. ISO is reported to be approximately 20 to 100 times stronger than fentanyl, a substance already known for its role in the opioid overdose crisis.
What Is Isotonitazene?
Isotonitazene is a synthetic opioid that was originally developed in the 1950s for pain relief but was never approved for medical use due to its high potency and risk of overdose. Recently, it has been found in various forms, including powder and counterfeit pills, often mixed with other substances like heroin or cocaine. Users may be unaware that they are consuming ISO, leading to accidental overdoses.
Health Risks and Overdose Potential
The extreme potency of Isotonitazene means that even a small amount can be lethal. Health experts warn that traditional doses of naloxone, the opioid overdose reversal drug, may not be sufficient to counteract an ISO overdose. Multiple administrations of naloxone may be required, and in some cases, even that may not be enough to save a life.
Spread and Detection Challenges
ISO has been detected in several U.S. states, including Florida, where it was found in counterfeit pills resembling oxycodone. Law enforcement agencies are working to identify and intercept shipments of this dangerous substance. However, the unregulated nature of the illicit drug market makes it challenging to track and control the distribution of Isotonitazene.
Public Health Response
Authorities are urging the public to avoid purchasing drugs from unregulated sources and to be aware of the risks associated with synthetic opioids. Harm reduction strategies, such as the availability of naloxone and public education campaigns, are being emphasized to combat the rising threat posed by Isotonitazene and other potent synthetic opioids.
Leave a Reply